Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11182-11198
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11182
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11182
Table 1 Selected pancreatic ductal adenocarcinoma genetic risk factors
Risk factor | Gene | Increased PDAC risk | Other associated cancers |
Hereditary breast and ovarian cancer syndrome | BRCA1, BRCA2, PALB2 | 2-3.5 | Breast, ovarian, prostate |
Lynch syndrome (hereditary non-polyposis colorectal cancer) | MLH1, MSH2, MSH6, PMS2, EPCAM | 8.6 | Colon, endometrium, ovary, stomach, small intestine, urinary tract, brain, cutaneous sebaceous glands |
Familial adenomatous polyposis | APC | 4.5-6 | Colon, desmoid, duodenum, thyroid, brain, ampullary, hepatoblastoma |
Peutz-Jeghers syndrome | STK11/LKB1 | 132 | Esophagus, stomach, small intestine, colon, lung, breast, uterus, ovary |
Familial atypical multiple mole melanoma pancreatic carcinoma syndrome | P16INK4A/CDKN2A | 47 | Melanoma |
Hereditary pancreatitis | PRSS1, SPINK1 | 69 | |
Cystic fibrosis | CFTR | 3.5 | |
Ataxia-telangiectasia | ATM | Increased | Leukemia, lymphoma |
Non-O blood group | 1.3 | ||
Familial pancreatic cancer | Unknown | 9 (1 FDR) 32 (3 FDRs) |
- Citation: Becker AE, Hernandez YG, Frucht H, Lucas AL. Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection. World J Gastroenterol 2014; 20(32): 11182-11198
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11182.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11182